BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Nuno P. Santos, Paula A. Oliveira, Regina Arantes-Rodrigues, Ana I. Faustino-Rocha, Aura Colaço, Carlos Lopes, Rui M. Gil da Costa. Cytokeratin 7/19 expression inN-diethylnitrosamine-induced mouse hepatocellular lesions: implications for histogenesisInternational Journal of Experimental Pathology 2014; 95(3): 191 doi: 10.1111/iep.12082
2
Anne Bessard, Christophe Frémin, Frédéric Ezan, Alexandre Coutant, Georges Baffet. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cellsJournal of Cellular Physiology 2007; 212(2): 526 doi: 10.1002/jcp.21049
3
Femke Heindryckx, Isabelle Colle, Hans Van Vlierberghe. Experimental mouse models for hepatocellular carcinoma researchInternational Journal of Experimental Pathology 2009; 90(4): 367 doi: 10.1111/j.1365-2613.2009.00656.x
4
Bin-Wen Wu, Yuan Wu, Jia-Long Wang, Ju-Sheng Lin, Shu-Yu Yuan, Ai Li, Wu-Ren Cui. Study on the mechanism of epidermal growth factor-induced proliferation of hepatoma cellsWorld Journal of Gastroenterology 2003; 9(2): 271-275 doi: 10.3748/wjg.v9.i2.271
5
Qiang Zuo, Hui Huang, Min Shi, Futing Zhang, Jiping Sun, Jianping Bin, Yulin Liao, Wangjun Liao. Multivariate Analysis of Several Molecular Markers and Clinicopathological Features in Postoperative Prognosis of Hepatocellular CarcinomaThe Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology 2012; 295(3): 423 doi: 10.1002/ar.21531
6
Jason Foster, Jennifer Black, Charles LeVea, Thaer Khoury, Boris Kuvshinoff, Miland Javle, John F. Gibbs. COX-2 Expression in Hepatocellular Carcinoma is an Initiation Event; While EGF Receptor Expression with Downstream Pathway Activation is a Prognostic Predictor of SurvivalAnnals of Surgical Oncology 2007; 14(2): 752 doi: 10.1245/s10434-006-9123-8
7
Isabel Schulien, Peter Hasselblatt. Methods in Cell Biology 2020;  doi: 10.1016/bs.mcb.2020.08.006
8
Xue-Liang Guo, Geng-Jin Lin, Hong Zhao, Yong Gao, Li-Ping Qian, San-Rong Xu, Li-Na Fu, Qing Xu, Jie-Jun Wang. Inhibitory effects of docetaxel on expression of VEGF, bFGF and MMPs of LS174T cellWorld Journal of Gastroenterology 2003; 9(9): 1995-1998 doi: 10.3748/wjg.v9.i9.1995
9
Steven Nathaniel Steinway, Jorge Gomez Tejeda Zañudo, Paul J Michel, David J Feith, Thomas P Loughran, Reka Albert. Combinatorial interventions inhibit TGFβ-driven epithelial-to-mesenchymal transition and support hybrid cellular phenotypesnpj Systems Biology and Applications 2015; 1(1) doi: 10.1038/npjsba.2015.14
10
Zhi-Jun Tan, Xian-Gui Hu, Gui-Song Cao, Yan Tang. Analysis of gene expression profile of pancreatic carcinoma using cDNA microarrayWorld Journal of Gastroenterology 2003; 9(4): 818-823 doi: 10.3748/wjg.v9.i4.818
11
Zhao-Shan Niu, Bo-Kian Li, Mei Wang. Expression of p53 and C-myc genes and its clinical relevance in the hepatocellular carcinomatous and pericarcinomatous tissuesWorld Journal of Gastroenterology 2002; 8(5): 822-826 doi: 10.3748/wjg.v8.i5.822
12
Lun-Xiu Qin, Zhao-You Tang. The prognostic molecular markers in hepatocellular carcinomaWorld Journal of Gastroenterology 2002; 8(3): 385-392 doi: 10.3748/wjg.v8.i3.385
13
Min Zheng, Lian-Xin Liu, An-Long Zhu, Shu-Yi Qi, Hong-Chi Jiang, Zhu-Ying Xiao. <i>K-ras</i> gene mutation in the diagnosis of ultrasound guided fine-needle biopsy of pancreatic massesWorld Journal of Gastroenterology 2003; 9(1): 188-191 doi: 10.3748/wjg.v9.i1.188
14
Xiangjun Sun, Xinfeng Ge, Zhiyong Xu, Dongfeng Chen. Identification of circular RNA–microRNA–messenger RNA regulatory network in hepatocellular carcinoma by integrated analysisJournal of Gastroenterology and Hepatology 2020; 35(1): 157 doi: 10.1111/jgh.14762
15
Chun-Ming Wong, Irene O. L. Ng. Molecular pathogenesis of hepatocellular carcinomaLiver International 2007; 28(2): 160 doi: 10.1111/j.1478-3231.2007.01637.x
16
Guo-Qing Han, Cheng-Yong Qin, Rong-Hua Shu. The analysis of &gamma;-glutamyl transpeptidase gene in different type liver tissuesWorld Journal of Gastroenterology 2003; 9(2): 276-280 doi: 10.3748/wjg.v9.i2.276
17
Chuangye Han, Xiwen Liao, Wei Qin, Long Yu, Xiaoguang Liu, Gang Chen, Zhengtao Liu, Sicong Lu, Zhiwei Chen, Hao Su, Guangzhi Zhu, Zili Lu, Zhiming Liu, Xue Qin, Ying Gui, Zengnan Mo, Lequn Li, Tao Peng. EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinomaScientific Reports 2016; 6(1) doi: 10.1038/srep31237
18
Chun Ming Wong, Judy Wai Ping Yam, Irene O. L. Ng. Molecular Genetics of Liver Neoplasia2010; : 373 doi: 10.1007/978-1-4419-6082-5_20
19
Chengxin Wang, Hongyan Zhou, Xiaonan You, Xiji Shu, Yan Li, Xiaoling Zhao. An investigation of the potential malignant characteristics of endometriosisChinese Journal of Clinical Oncology 2005; 2(6): 861 doi: 10.1007/BF02789655
20
Zheng-Xu Wang, Gui-Fang Hu, Hong-Yang Wang, Meng-Chao Wu. Expression of liver cancer associated gene HCCA3World Journal of Gastroenterology 2001; 7(6): 821-825 doi: 10.3748/wjg.v7.i6.821
21
Chunming Wong, Irene Oi Lin Ng. Primary Liver Cancer2012; : 45 doi: 10.1007/978-3-642-28702-2_3
22
Kelly Garcia, Dan Regan. Bigger Is Better: Refinement of an Animal Model of Hepatocellular Carcinoma and Transfemoral Arterial EmbolizationJournal of Vascular and Interventional Radiology 2017; 28(7): 1051 doi: 10.1016/j.jvir.2017.04.020
23
Ah-Reum Oh, Seung-Ku Lee, Min-Ho Kim, Jae-Youn Cheong, Sung-Won Cho, Kap-Seok Yang, Kyu-Bum Kwack. Polymorphisms in RAS Guanyl-releasing Protein 3 are Associated with Chronic Liver Disease and Hepatocellular Carcinoma in a Korean PopulationGenomics & Informatics 2008; 6(4): 181 doi: 10.5808/GI.2008.6.4.181
24
Lun-Xiu Qin, Zhao-You Tang, Zeng-Chen Ma, Zhi-Quan Wu, Xin-Da Zhou, Qing-Hai Ye, Yuan Ji, Li-Wen Huang, Hu-Liang Jia, Hui-Chuan Sun, Lu Wang. p53 immunohistochemical scoring: an independent prognostic marker for patients after hepatocellular carcinoma resectionWorld Journal of Gastroenterology 2002; 8(3): 459-463 doi: 10.3748/wjg.v8.i3.459